Epigenetic regulation of mmp-9 gene expression (Q38062851)

28 August 2017

1 reference

title

Epigenetic regulation of mmp-9 gene expression (English)

1 reference

28 August 2017

1

Marilyne Labrie

1 reference

28 August 2017

Yves St-Pierre

2

1 reference

28 August 2017

27 November 2012

1 reference

Cellular and Molecular Life Sciences

28 August 2017

1 reference

28 August 2017

70

1 reference

28 August 2017

17

1 reference

28 August 2017

3109-3124

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-012-1214-z

28 August 2017

0 references

cites work

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Avoiding spam in the proteolytic internet: future strategies for anti-metastatic MMP inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Regulation of matrix metalloproteinase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

The regulation of AP-1 activity by mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated prot

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Interferons inhibit tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 activation via interferon regulatory factor-1 binding competition with NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-κB-dependent matrix metalloproteinase-9 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-kB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

What we learn from transformation suppressor genes: lessons from RECK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

RECK negatively regulates matrix metalloproteinase-9 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Induced expression of MMP-9 in C6 glioma cells is inhibited by PDGF via a PI 3-kinase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Disruption of an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

EGR-1 activation by EGF inhibits MMP-9 expression and lymphoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Targeted knockdown of EGR-1 inhibits IL-8 production and IL-8-mediated invasion of prostate cancer cells through suppressing EGR-1/NF-kappaB synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

21 January 2018

The epigenotype. 1942.

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Hypomethylation distinguishes genes of some human cancers from their normal counterparts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Epigenetic therapy of cancer: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Coordination of cell signaling, chromatin remodeling, histone modifications, and regulator recruitment in human matrix metalloproteinase 9 gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Interferon-gamma-activated STAT-1alpha suppresses MMP-9 gene transcription by sequestration of the coactivators CBP/p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Enhancing the anti-angiogenic action of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Modulation of matrix metalloproteinase activity in human thyroid cancer cell lines using demethylating agents and histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Inhibition of histone deacetylase activity down-regulates urokinase plasminogen activator and matrix metalloproteinase-9 expression in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Inhibition of histone deacetylase activity in human endometrial stromal cells promotes extracellular matrix remodelling and limits embryo invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Depsipeptide (FK228) inhibits growth of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

HDACi--going through the mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Discovery and development of SAHA as an anticancer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-kappaB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Histone methylation: a dynamic mark in health, disease and inheritance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Reduced exploration, increased anxiety, and altered social behavior: Autistic-like features of euchromatin histone methyltransferase 1 heterozygous knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Haploinsufficiency of NSD1 causes Sotos syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Epigenetic regulation of aging stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Establishing, maintaining and modifying DNA methylation patterns in plants and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

The DNA methyltransferases of mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

CpG methylation is maintained in human cancer cells lacking DNMT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

The role of DNA hypomethylation in the control of stromelysin gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Protein kinase D mediates mitochondrion-to-nucleus signaling and detoxification from mitochondrial reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Protein kinase D1 inhibits cell proliferation through matrix metalloproteinase-2 and matrix metalloproteinase-9 secretion in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Mammalian microRNAs predominantly act to decrease target mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

The therapeutic potential of microRNAs: disease modulators and drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Expression of MicroRNA-146a in osteoarthritis cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Methylation inhibitor therapy in the treatment of myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Matrix metalloproteinase-9 regulates MUC-2 expression through its effect on goblet cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Butyrate regulates the expression of c-Src and focal adhesion kinase and inhibits cell invasion of human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 and its promoter. Specific lack of expression in neoplastic JB6 cells may reflect altered gene methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Inhibition of VLA-4 and up-regulation of TIMP-1 expression in B16BL6 melanoma cells transfected with MHC class I genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Frequent hypermethylation of 5' flanking region of TIMP-2 gene in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Interaction of 5-aza-2'-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Aberrant gene expression in human non small cell lung carcinoma cells exposed to demethylating agent 5-aza-2 '-deoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Epigenetic inactivation of the tissue inhibitor of metalloproteinase-2 (TIMP-2) gene in human prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Differential regulation of gelatinase b and tissue-type plasminogen activator expression in human bowes melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1214-Z

Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.

21 January 2018

1 reference

12 December 2020

The rabbit gene for 92-kDa matrix metalloproteinase. Role of AP1 and AP2 in cell type-specific transcription.

1 reference

12 December 2020

Effect of microRNA-206 on cytoskeleton remodelling by downregulating Cdc42 in MDA-MB-231 cells.

1 reference

12 December 2020

A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice

1 reference

12 December 2020

Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis.

1 reference

12 December 2020

Lack of suppression of tumor cell phenotype by overexpression of TIMP-3 in mouse JB6 tumor cells identification of a transfectant with increased tumorigenicity and invasiveness.

1 reference

12 December 2020

Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion

1 reference

12 December 2020

Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B

1 reference

12 December 2020

Histone lysine methylation and demethylation pathways in cancer

1 reference

12 December 2020

Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers.

1 reference

12 December 2020

Transcriptional control of the RECK metastasis/angiogenesis suppressor gene

1 reference

12 December 2020

HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1

1 reference

12 December 2020

5-Aza-2'-deoxycytidine and interleukin-1 cooperate to regulate matrix metalloproteinase-3 gene expression

1 reference

12 December 2020

The anti-leukemic effect and molecular mechanisms of novel hydroxamate and benzamide histone deacetylase inhibitors with 5-aza-cytidine

1 reference

12 December 2020

Phosphorylation of human DNMT1: implication of cyclin-dependent kinases

1 reference

12 December 2020

Unique regulation of the matrix metalloproteinase, gelatinase B

1 reference

12 December 2020

The Ets transcription factors of the PEA3 group: transcriptional regulators in metastasis

1 reference

12 December 2020

The anti-leukemic effect of a novel histone deacetylase inhibitor MCT-1 and 5-aza-cytidine involves augmentation of Nur77 and inhibition of MMP-9 expression

1 reference

12 December 2020

Nitric oxide (NO), methylation and TIMP-1 expression in BL6 melanoma cells transfected with MHC class I genes

1 reference

12 December 2020

Effect of sodium butyrate on pro-matrix metalloproteinase-9 and -2 differential secretion in pediatric tumors and cell lines.

1 reference

12 December 2020

Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB el

1 reference

12 December 2020

Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1

1 reference

12 December 2020

Shortened microsatellite d(CA)21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene

1 reference

12 December 2020

Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression

1 reference

12 December 2020

Specific methylation events contribute to the transcriptional repression of the mouse tissue inhibitor of metalloproteinases-3 gene in neoplastic cells

1 reference

12 December 2020

Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.

1 reference

12 December 2020

The epigenetic breakdown of cancer cells: from DNA methylation to histone modifications

1 reference

12 December 2020

Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate

1 reference

12 December 2020

Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model

1 reference

12 December 2020

Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.

1 reference

12 December 2020

Prolonged butyrate treatment inhibits the migration and invasion potential of HT1080 tumor cells.

1 reference

12 December 2020

Genome-scale DNA methylation maps of pluripotent and differentiated cells

1 reference

12 December 2020

Valproic acid affected the survival and invasiveness of human glioma cells through diverse mechanisms.

1 reference

12 December 2020

10.1007/S00018-012-1214-Z

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23184252